EDWARDS LIFESCIENCES CORP (EW) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:EW - US28176E1082 - Common Stock
83.1 USD
-0.74 (-0.88%)
83.1 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to EW. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 97.12. This target is 16.87% above the current price.
- EW was analyzed by 42 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EW.
- In the previous month the buy percentage consensus was at a similar level.
- EW was analyzed by 42 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-12 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-12 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-09 | TD Cowen | Upgrade | Hold -> Buy |
| 2026-01-07 | Stifel | Maintains | Buy -> Buy |
| 2025-12-18 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-12-16 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-05 | BTIG | Maintains | Buy -> Buy |
| 2025-12-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-05 | Stifel | Maintains | Buy -> Buy |
| 2025-12-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-05 | Truist Securities | Maintains | Hold -> Hold |
| 2025-12-05 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-05 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-25 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-03 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-03 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-10-31 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-31 | Stifel | Maintains | Buy -> Buy |
| 2025-10-31 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-31 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-31 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-31 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-31 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-29 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
EDWARDS LIFESCIENCES CORP / EW FAQ
Can you provide the average price target for EDWARDS LIFESCIENCES CORP stock?
42 analysts have analysed EW and the average price target is 97.12 USD. This implies a price increase of 16.87% is expected in the next year compared to the current price of 83.1.
Can you provide the consensus rating for EDWARDS LIFESCIENCES CORP stock?
The consensus rating for EDWARDS LIFESCIENCES CORP (EW) is 79.5238 / 100 . This indicates that analysts generally have a positive outlook on the stock.